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INTRODUCTION
Neurotrophism and latent infection are common character-
istics of herpes virus (1-3). Concurrent reactivation of herpes
simplex virus (HSV) and varicella zoster virus (VZV), how-
ever, is rare, and this may be due to their different biologic
features such as recurrence rate, age of reactivation, reacti-
vating cause, resident site in latency, etc. Until now, the simul-
taneous reactivation of the two herpesviruses has mainly been
reported in immunocompromised patients (4-10), probably
because immunosuppressed patients are predisposed to infec-
tion and because the clinical features in immunosuppresed
patients are more severe and extensive. 
We report here an immunocompetent patient with con-
current reactivation of HSV and VZV.
CASE REPORT
An 8-yr-old female presented with asymptomatic grouped
vesicles on the right lower eyelid and right upper gluteal
region and thigh, which appeared simultaneously the day
before visit. She had no history of chronic diseases other than
recurrent herpes simplex on the right lower eyelid over the
previous 2 yr. On physical examination, no abnormal find-
ings other than the skin lesions on the right lower eyelid
and the right L2 dermatome were observed (Fig. 1). Chest
radiography and laboratory tests, including complete blood
cell count, liver function test, level of BUN and Cr, level of
immunoglobulins, T cell subset counts, and HIV antibody
were in normal ranges. Serologic tests were positive for VZV
and HSV IgG, weakly positive for VZV IgM, although they
were negative for HSV IgM. For further testing, PCR for
HSV and VZV DNA were performed using skin obtained
from the lesions on the face and thigh. Results were positive
for HSV and negative for VZV for the facial skin and vice
versa for the thigh skin (Fig. 2). She was subsequently diag-
nosed with herpes simplex of the face and herpes zoster of
the right L2 dermatome and was treated with famciclovir at
a dose of 125 mg three times a day for 7 days; both groups
of lesions resolved following the treatment.
DISCUSSION 
HSV and VZV are members of the herpesvirinae subfam-
ily. These viruses characteristically cause recurrent infection
following latency within the dorsal root and trigeminal gan-
glia and possess the ability to shift between the latent site in
the sensory ganglia and the corresponding innervated skin
(1-3). Despite these similarities, their biological properties
differ significantly and such differences may explain why con-
current reactivation is rare. 
Among other things, herpes zoster and herpes simplex dif-
fer in the frequency of recurrence and age at reactivation (1).
HSV is reactivated several times during life, but VZV reac-
tivation generally occurs only once through life. VZV reac-
tivation is associated with aging, with the highest incidence
rate occurring after 60 yr of age, probably due to a decline
in cellular immune response with age (11). HSV is more fre-
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Latency within the nervous system is a characteristic feature of herpesviridae
infection. It is reactivated by triggering factors such as UV exposure, stress, and
trauma. Simultaneous reactivation of herpes simplex and herpes zoster is uncom-
mon, however, an observation provably explained by differences in the trigerring
mechanism. Concurrent reactivation of herpes simplex virus (HSV) and varicella
zoster virus (VZV) is occasionally encountered in immunosuppressed patients; on
the other hand, it is rarely reported in immunocompetent individuals. We present
the case of an immunocompetent 8-yr-old female patient with concurrent reactiva-
tion of HSV on the face and VZV on the right L2 dermatome.
Key Words : Herpesvirus 3, Human; Simplexvirus; Herpesvirus 1, Human
Received : 4 July 2003
Accepted : 8 September 2003Concurrent Reactivation of VZV and HSV in an Immunocompetent Child 599
quently reactivated in children and the recurrence declines
with age due to maturation of immune response (12). The
reactivating cause also differs between these viruses. HSV is
reactivated by predisposing factors such as UV exposure,
trauma, fever, and stress, but the provocation factors are less
apparent in the case of VZV (8). This may be due to direct
influence this factors on HSV gene expression (2). The sites
of viral dormancy are also thought to be different; HSV lies
latent in neuronal cells and VZV in satellite cells (1, 2). Con-
sequently, reactivated HSV causes skin lesions limited to the
immediate area of innervation of the infected neurons, while
reactivated VZV brings about extensive viral proliferation
and cell-to-cell infection in the larger dermatomal area (1, 2).
VZV occasionally cause extensive inflammation, atrophy, and
scarring of the dorsal horn and root ganglion, which results
in postherpetic neuralgia (13). 
The infrequency of reports on simultaneous recurrence of
herpes simplex and herpes zoster may be explained by the
differences in the rate of viral reactivation, frequency of viral
reactivation, factors that trigger viral reactivation, and his-
tologic sites of viral latency (10). However, it is difficult to
determine whether the course of disease are altered by each
virus because there is only small number of reports of simul-
taneous herpes simplex and herpes zoster (8). 
Report on concurrent reactivation of HSV and VZV are
rare. We found seven reports on concurrent infection of them
in the literature (4-10). All patients in the reports were ado-
lescent or adult and their age distribution is from 22 to 84
yr old. Five patients among them were in the immune-sup-
pressed condition or chronic illness such as kidney recipient
(4), AIDS (5), lung cancer (6), tuberculosis (7), idiopathic
thrombocytopenic purpura (8) and two others are healthy
patients (9, 10). Gibney et al. (4) suggested that reactivation
of a latent virus is associated with depression of cell-mediat-
ed immune responses due to primary infection with another
herpesvirus. Vivo et al. (6) reported VZV infection on the
right V2 dermatome and HSV infection on the right side of
palate in a 84-yr-old male with non-small-cell lung cancer;
they suggested that a common triggering event may exist
to reactivate both viruses in the same sensory ganglion. 
These viruses do infect healthy children and adults but the
manifestations are more severe and extensive in the immuno-
compromised individuals. Although some of the reactivated
patients were healthy, most of the patients had chronic or
immunocompromising diseases. These reports show that
concurrent reactivation of HSV and VZV is generally pre-
ceded by immunologic abnormalities. 
The subject of this study is a healthy child with no history
of medical problems and no abnormality in laboratory data,
including immunologic parameters. Serologic tests have only
small role in the diagnosis of recurrent herpes simplex and
late stage of herpes zoster because of seroconversion. How-
ever, positive VZV IgG and weakly positive VZV IgM sug-
gest acute VZV reactivation on the thigh. Positive HSV IgG
and negative HSV IgM suggest recurrent herpes simplex on
Fig. 1. (A) Grouped vesicles on the right cheek and right L2 der-
matome. (B) Grouped multiple vesicles on the infraorbital area.
Herpes simplex virus was detected in this lesion. (C) Grouped
vesicles and erythematous patches over the L2 dermatome. Vari-
cella zoster virus was detected in these lesion.
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Fig. 2. (A) HSV PCR electrophoresis.
Lane M, 100 bp DNA size marker; Lane
1, Positive control; Lane 2, HSV detect-
ed in patient’s face; Lane 3, HSV is not
detected in patient’s thigh; Lane 4, Posi-
tive control; Lane 5, Negative control
(PCR); Lane 6, Negative control (prep).
(B) VZV PCR electrophoresis. Lane M,
Marker VI; Lane 1, VZV detected in the
patient’s thigh; Lane 2, VZV is not detect-
ed in the patient’s face; Lane 3, Positive
control.
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the face. PCR supported the differential diagnosis of HSV
and VZV on the other sites. 
Concurrent reactivation of HSV and VZV is generally
occurred in the immunocompromised patients and rarely
reported in the immunocompetent patients. To date no report
has been made on concurrent reactivation of these viruses in
children; this is probably due to a low incidence of pediatric
VZV infection compared with that in adults (14). 
The present case is unique in that the patient is an immuno-
competent child. The authors believe this to be the first report-
ed case of simultaneous reactivation of HSV and VZV in
different skin regions in an immunocompetent child. How-
ever, our case suggest that HSV and VZV could occasionally
overlapped regardless of general condition and age. And it
is suggested that the reactivation of HSV would have depressed
cell mediated immunity and allowing reactivation of VZV,
or vice versa.
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